Vivozon Pharmaceutical cuts convertible bond conversion price to KRW 3,001 from KRW 4,827
Bitget2026/10/12 06:52- Vivozon Pharmaceutical reset the conversion price on its 21st convertible bond to KRW 3,001 from KRW 4,827, effective Oct. 12, 2026.
- Adjustment raised shares issuable on the KRW 3 billion outstanding principal to 999,666 from 621,504.
- Reset was triggered by a drop in the stock’s market price, within a KRW 2,500 floor.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
ECB’s Dolenc says central bank may not have to do as much if markets tighten
BlackRock CEO Larry Fink warns: AI infrastructure has become the backbone of the US economy, halting data center construction will trigger a recession
BlackRock CEO Larry Fink has issued a rare recession warning, stating that if the United States imposes any form of moratorium on data center construction, the economy will plunge directly into recession. As the midterm elections approach, the construction of AI infrastructure has escalated from a business issue to a political bombshell. Analysts predict that AI capital expenditures could surpass 1 trillion dollars by 2027. Any disruption in policy would trigger a chain reaction impacting the supply chain, job market, and energy industry.
BTC market dominance rises to 60.46%
AI Debt Glut May Be Pushing Up US Government Borrowing Costs, BondCliQ CEO Says
Crypto prices
More
